Bausch Health (BHC)
(Delayed Data from NYSE)
$7.12 USD
-0.01 (-0.14%)
Updated May 14, 2024 04:00 PM ET
After-Market: $7.20 +0.08 (1.12%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Brokerage Reports
Bausch Health Cos Inc. [BHC]
Reports for Purchase
Showing records 141 - 148 ( 148 total )
Company: Bausch Health Cos Inc.
Industry: Medical - Generic Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Generic Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Generic Drugs
Legacy SEC Investigation Resolved; Liver Disease Portfolio Broadened; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Further Progress Made on Multiple Fronts; Raising Price Target to $25
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Multiple Positive Developments; Awaiting Further Organic Growth; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
New Name and Perhaps Brighter Future; Generics Could Make Growth Challenging; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R